GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery, announced today that the first shoulder surgeons in the United States and Europe have reported excellent experiences with the industry’s only intraoperative wireless shoulder sensor, Equinoxe® with VERASENSE™. The innovative technology enhances Exactech’s flagship reverse shoulder system, enabling surgeons to measure dynamic loads on the humeral insert, a key factor that is important to surgeons to ensure a successful outcome after shoulder replacement surgery.
“The technology’s intraoperative data provides objective, real-time feedback of joint compression loads throughout the range of motion, which allows me to make informed decisions regarding soft tissue tension,” said Ari Youderian, MD, who performed the first U.S. surgery in California last week.
VERASENSE’s proprietary sensor technologies transmit data wirelessly to an intraoperative monitor that enables surgeons to make informed decisions on load magnitude and center of load location in real time.
In addition to Dr. Youderian’s surgery, Pierre-Henri Flurin, MD, of the Clinique du Sport in Bordeaux, recently performed the first European surgery in France.
“I’m excited about the impact this technology may have on clinical outcomes and patient satisfaction, especially when combined with ExactechGPS® shoulder navigation,” said Dr. Flurin. “Both provide greater intraoperative visibility and more data, allowing me to make informed decisions using this data in real time.”
Flurin and Youderian, both Exactech design team members, were among the first to use ExactechGPS with the latest software update, incorporating a new feature designed to verify implant placement*.
“Exactech’s growing portfolio of innovative technologies, such as VERASENSE and ExactechGPS, allow us to provide surgeons with the tools they need to help patients get back to what they love faster,” said Vice President of Extremities Chris Roche. “We are very proud of our partnership with OrthoSensor and look forward to even more surgeries around the world with this unique technology.”
Increased availability of VERASENSE is expected in the first half of 2021. To learn more about VERASENSE or the ExactechGPS Shoulder Application, visit exac.com.
*Images/3D models shown on the GPS screen are accurate at +/-2mm or degrees. In vitro (bench) test results may not necessarily be indicative of clinical performance.
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases, such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at http://www.exac.com.
About OrthoSensor, Inc.
OrthoSensor, Inc., a leader in Sensor-Assisted Total Knee Arthroplasty, develops and commercializes intelligent orthopedic devices and data services that provide quantitative feedback to surgeons and hospitals. The sensor utilizes advanced proprietary sensor and communications technologies, coupled with the company’s innovative software products, to facilitate evidence-based decisions in orthopaedic surgery – with the goal of improving patient outcomes and potentially reducing the cost of treating musculoskeletal disease.
OrthoSensor® VERASENSE™ and OrthoLogIQ® are trademarks of OrthoSensor, Inc.
Priscilla Bennett, APR
Vice President, Corporate and Marketing Communications